ReviewFrontiers in pharmacology2021

The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells.

Parin Rattananon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.